The Price of Free Data

The Supreme Court’s recent ruling that companies cannot patent parts of naturally-occurring human genes represents a game-changer for healthcare and the medical and biotechnology industries.

Open science is not a new goal; scientific progress has always predicated on the free and open exchange of ideas. Read more....